Post by icemandios on Aug 26, 2023 16:06:20 GMT
Although we’ve been told Pfizer’s COVID-19 vaccine is manufactured with harmless messenger RNA (mRNA), the U.S. Food and Drug Administration’s (FDA) product label shows it contains artificially modified RNA—a key ingredient that is not naturally occurring and poses a substantial risk to human health.
According to Pfizer and BioNTech’s COVID-19 vaccine label in the FDA’s Fact Sheet for Healthcare Providers, each Pfizer vaccine dose for children ages 5 through 11 contains 10 micrograms (mcg) of modRNA, while fully-approved Comirnaty authorized for use in individuals 12 years of age and older contains 30 mcg of modRNA.
Unlike mRNA, modRNA modifies one of four compounds in RNA that make it last longer in the body, less immunogenic (reduced stimulation of the innate immune system), and more efficient at producing a protein—in this case, the spike protein, Mr. Steger stated. Since modRNA cannot target specific cells to make viral protein, it can attack perfectly healthy cells and bypass protective barriers in the body, like the blood-brain barrier.
“It is my opinion that, at a minimum, the intentional use of mRNA—an acronym well-known to stand for messenger RNA along with the endless statements about the vaccines being based on naturally occurring messenger RNA constitute misbranding in violation of a number of laws,” Ohio-based attorney Thomas Renz told The Epoch Times in an email.
“There is a legal and moral duty to provide informed consent, and to misrepresent a drug that was intended to be a gene therapy as a vaccine containing “natural messenger RNA” is an apparent violation of both of those duties.”
“There is a legal and moral duty to provide informed consent, and to misrepresent a drug that was intended to be a gene therapy as a vaccine containing “natural messenger RNA” is an apparent violation of both of those duties.”
Biontech logo
Manufactured for
BioNTech Manufacturing GmbH
An der Goldgrube 12
55131 Mainz, Germany
Logo
Manufactured by
Pfizer Inc., New York, NY 10017
LAB-1450-31.0
Revised: 22 December 2022
END SHORT VERSION FACT SHEET
Long Version (Full EUA Prescribing Information) Begins On Next Page
1 Certain kinds of immunocompromise refers to individuals who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
2 When prepared according to their respective instructions for use, the FDA-approved COMIRNATY (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older can be used interchangeably without presenting any safety or effectiveness concerns.
3 Notwithstanding the age limitations for use of the different formulations and presentations described above, individuals who will turn from 11 years to 12 years of age between doses in the primary regimen may receive, for any dose in the primary regimen, either: (1) the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 5 through 11 years of age (each 0.2 mL dose containing 10 mcg modRNA, supplied in multiple dose vials with orange caps); or (2) COMIRNATY (COVID-19 Vaccine, mRNA) or the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 12 years of age and older (each 0.3 mL dose containing 30 mcg modRNA, supplied in multiple dose vials with gray caps and multiple dose vials with purple caps).
4 Vaccination providers administering COMIRNATY (COVID-19 Vaccine, mRNA) must adhere to the same reporting requirements.
[It is commonly known that Pfizer was granted immunity from lawsuits as provided by the Emergency Use Authorization (EUA) under which the vaccine was developed. However, it seems likely that such a mislabling of the product could negate that shield of immunity.]
